Report Company Directory

CSPC INNOVATION PHARMACEUTICAL CO L

• Regional Morning Meeting Notes: Monday, August 18, 2025 by UOB
• CSPC Innovation Pharmaceutical Co (300765 CH): 1H25: Results in line, smooth progress in R&D. by UOB
• Greater China Daily: Monday, August 18, 2025 by UOB
• Regional Morning Meeting Notes: Thursday, July 31, 2025 by UOB
• China Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. by UOB
• China Healthcare Bi-weekly: Gaining strength on robust earnings outlook and pipeline growth. Maintain OVERWEIGHT. by UOB
• Regional Morning Meeting Notes: Wednesday, July 16, 2025 by UOB
• Regional Morning Meeting Notes: Thursday, June 19, 2025 by UOB
• China Healthcare: Entering a new phase of accelerated growth. Upgrade to OVERWEIGHT. by UOB
• China Healthcare: Drug Innovators Continue To Drive Market Growth by UOB

CSPC Pharmaceutical Group Limited

• Regional Morning Meeting Notes: Monday, August 25, 2025 by UOB
• Regional Morning Meeting Notes: Thursday, July 31, 2025 by UOB
• Regional Morning Meeting Notes: Wednesday, July 16, 2025 by UOB
• Regional Morning Meeting Notes: Thursday, June 19, 2025 by UOB
• Regional Morning Meeting Notes: Friday, May 30, 2025 by UOB
• CSPC Pharmaceutical Group Limited: 1 director by SmartInsider
• Regional Morning Meeting Notes: Friday, January 17, 2025 by UOB
• Regional Morning Notes - Wednesday, October 11, 2023 by UOB
• China Healthcare: Striving for growth in 2025. by UOB
• Regional Morning Meeting Notes: Monday, November 18, 2024 by UOB

CSR

• APAC Focus: Australian BMAT & Steel Sector "Surplus Property winners" Power by UBS AG
• Australian Equity Strategy "Sector recommendations and best stock ideas"... by UBS AG
• Australian Equity Strategy "Why falling inflation may not be so good for..." by UBS AG
• First Read: Saint Gobain "Acquisition of CSR in Australia" (Buy) Kuglitsch by UBS AG
• Boral "Solid beat on cost control" (Neutral) Power by UBS AG
• Australian Equity Strategy "UBS Research Best Stock Ideas" Schellbach by UBS AG
• Daily Commodities Note "Iron ore soft ahead of Lunar New Year holidays" Shaw by UBS AG
• UBS Stock Update "Recent changes to UBS ratings, price targets & EPS" Brown by UBS AG
• Australian Building Materials "Prefer USA names in February reporting..." by UBS AG
• CSR "Downgrade as share price performance ignores FY25 BMAT volume risk" (Sell) by UBS AG

CSRA Inc.

CSS Holdings Ltd.

• CSSホールディング(2304, NR) by Mizuho Securities
• Ford Equity International Rating and Forecast Report by Ford Equity Research